Cytel

Meet Victor Laliman-Khara, Research Principal at Cytel, who shares his passion for health economics in our latest Career Perspectives interview. Discover his journey, his thoughts on the importance of comparative effectiveness (CE) and Indirect Treatment Comparisons (ITCs), and how flexibility at work has shaped his career. Don't miss out on his insights! Read the full blog here: https://hubs.ly/Q03dTwts0 #CytelWithoutQuestion #CareerPerspectives

Are you joining us at COG Nordics next week? Meet our colleagues Anna Nilsson and Russell Brown at booth 9 while you are there and discover how, through our pioneering data analytics, we simplify the journey from conception to commercialization and increase the probability of success for your trials! Book your meeting here: https://hubs.ly/Q03dQFm70 #COGNordics #COG #ClinicalTrials

Clinical trial costs are rising, but that doesn’t have to derail your development pipeline. Kathryn Wright shares proven strategies that can help optimize clinical trial budgets without sacrificing quality or compliance. Read the post: https://hubs.ly/Q03dFcmH0 #biotech #pharma #clinicaldevelopment #drugdevelopment #clinicaltrials

Today we offer a special congratulations to our colleague Jasperlynn Kao, whose poster "From Toplines to Triumph: Visualizing the Pathways to Regulatory Approval" has won the Best in Stream Award at PHUSE Connect US!?? Want to know more on the poster? Jasperlynn is giving a complete webinar on this together with colleague Florence Le Maulf on May 14! Book your seat here already: https://hubs.ly/Q03dCKKy0

Executive Insights 2025 n?rmar sig, den 10:e april sl?r vi upp d?rrarna. Vi ?r glada att kunna presentera Johan Luthman, EVP & Head R&D p? Lundbeck, som delar sina insikter om hur man balanserar innovation, f?rnuft och aff?rsbeslut. F?rutom Johan Luthman kommer Katrine Kielos och Ashkan Fardost st? f?r ?rets tv? keynotes. L?s mer och anm?l ditt intresse h?r: https://hubs.ly/Q03dCKRy0 Eventet arrangeras av Cytel, Flerie, DNB // BACK BAY och Linc AB.

AI tools are transforming the role of #SAS #programmers, making them faster and more effective, but human expertise remains crucial in ensuring high-quality outcomes. Gowri Sivakumar Ambalavanan shares how the future of #programming lies in a hybrid approach that leverages both human expertise and #AI-driven efficiencies. Read the post: https://hubs.ly/Q03dtMh50

Struggling with rising clinical trial costs? Join us in our newest webinar to discover proven strategies for optimizing budgets without compromising quality. Learn how scalable, cost-efficient solutions can streamline oversight models and enhance operational efficiency, while ensuring flexible talent resourcing. Explore innovative models—from FSP to just-in-time staffing—that can be tailored to meet each project's unique demands. With global capability centers, top-tier talent, and cutting-edge technology, our experts will show you how to overcome geographic and budget challenges while ensuring seamless execution. Whether you're navigating budget constraints or rethinking your operational approach, this session is packed with actionable insights. Register here: https://hubs.ly/Q03dkRb40 #FSP #ClinicalTrials

Emerging Biopharma Companies (EBPs) are shaping the future of clinical research, driving nearly 200% growth in trial starts over the past decade. But with increasing complexity and data volume, ensuring high-quality, standardized data is more critical than ever. Outsourcing biometrics to CROs helps EBPs navigate regulatory hurdles, reduce risks, and improve efficiency—making the right CRO partnership a key success factor. In our latest white paper in collaboration with Frost & Sullivan and Bioforum, you get the latest insights on EBP trends, the evolving CRO landscape, and the role of advanced biometrics in regulatory success. Download your copy here: https://hubs.ly/Q03dgzc-0 #biometrics #biostatistics #emergingbiopharma #CRO #clinicaltrialsdatamanagement

When multiple #patient outcomes matter, how do we capture that in a single #statistic? Krishna P. and Cyrus Mehta discuss their adaptive #trial design approach, offering a powerful new way to evaluate #therapies when multiple outcomes ranked by #clinical importance drive decision-making. Read the post: https://hubs.ly/Q03d4bD50 #biotech #pharma #clinicaldevelopment #drugdevelopment #statistics #adaptivetrials

?? AI is rapidly reshaping the life sciences industry, but are we truly ready for what's next? While the long-term potential is promising, the pace of change is outpacing our preparedness. The rise of generative AI brings complex ethical questions that many of us are only beginning to explore. Join Walter Boyle, Cytel’s VP of DMC Biostatistics, and Allie DeLonay, Senior Data Scientist at SAS’s Data Ethics Practice, for a live, interactive discussion on the ethical implications of AI in clinical development and beyond. ?? The session will wrap up with an open forum—your chance to ask questions and share perspectives. ??? Don’t miss this important conversation! Register here: https://hubs.ly/Q03d2BGM0 #AI #Ethics #ClinicalDevelopment #ClinicalTrials